| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.2 |